Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to $2.6 million.

  • Ekso Bionics Holdings' Shares Outstanding (Weighted Average) rose 9320.53% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 9320.53%. This contributed to the annual value of $13.0 million for FY2022, which is 630.69% up from last year.
  • Per Ekso Bionics Holdings' latest filing, its Shares Outstanding (Weighted Average) stood at $2.6 million for Q3 2025, which was up 9320.53% from $2.2 million recorded in Q2 2025.
  • Ekso Bionics Holdings' Shares Outstanding (Weighted Average)'s 5-year high stood at $25.4 million during Q1 2025, with a 5-year trough of $1.2 million in Q2 2024.
  • In the last 5 years, Ekso Bionics Holdings' Shares Outstanding (Weighted Average) had a median value of $12.7 million in 2022 and averaged $11.2 million.
  • Per our database at Business Quant, Ekso Bionics Holdings' Shares Outstanding (Weighted Average) soared by 10212.43% in 2021 and then tumbled by 9109.04% in 2024.
  • Over the past 5 years, Ekso Bionics Holdings' Shares Outstanding (Weighted Average) (Quarter) stood at $12.2 million in 2021, then rose by 6.31% to $13.0 million in 2022, then grew by 8.57% to $14.1 million in 2023, then plummeted by 90.38% to $1.4 million in 2024, then surged by 93.21% to $2.6 million in 2025.
  • Its last three reported values are $2.6 million in Q3 2025, $2.2 million for Q2 2025, and $25.4 million during Q1 2025.